Update on Taiwan laboratory disposal

Paris, France, Eastleigh and Manchester, UK – 21 December 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international molecular diagnostics company with a broad portfolio of integrated technologies and services, announces an update to the conditional disposal of its laboratory in Taiwan, which it acquired as part of the Yourgene Health plc (“Yourgene”) acquisition completed on 8 September 2023.

On 13 June 2023, Yourgene announced the conditional divestment of its Taiwanese subsidiary, Yourgene Health Taiwan Co Ltd (“Yourgene Health Taiwan”), to INEX Innovate Pte Ltd (“INEX”), a Singapore-based molecular diagnostics company focused on women’s and fetal health, for proceeds of up to US$4m (approximately £3.2m).

As previously announced, the divestment is conditional upon Yourgene completing a pre-Closing restructure (the “Restructure”) to facilitate the transfer of retained people and assets to other Group companies, which must be approved by the Taiwanese Government, and INEX then being granted Taiwanese Government approval for the planned acquisition as required for non-Taiwanese acquirers. The Restructure is now complete, however the various approvals have taken significantly longer to achieve than originally anticipated and management do not expect the transaction to complete by the end of 2023 as previously announced.   

Both parties remain committed to completing the transaction and the Group is continuing to work with INEX to obtain the necessary approvals as quickly


Novacyt SA
James Wakefield, Non-Executive Chairman
James McCarthy, Acting Chief Executive Officer

+44 (0) 23 8074 8830

SP Angel Corporate Finance LLP (Nominated Adviser and Broker)
Matthew Johnson / Charlie Bouverat (Corporate Finance)
Vadim Alexandre / Rob Rees (Corporate Broking)
+44 (0)20 3470 0470

Deutsche Numis (Joint Broker)
Freddie Barnfield / Duncan Monteith / Michael Palser
+44 (0)20 7260 1000

Allegra Finance (French Listing Sponsor)
Rémi Durgetto / Yannick Petit
+33 (1) 42 22 10 10
r.durgetto@allegrafinance.com / y.petit@allegrafinance.com

Walbrook PR (Financial PR & IR)
Stephanie Cuthbert / Paul McManus /
Phillip Marriage / Alice Woodings
+44 (0)20 7933 8780 or novacyt@walbrookpr.com
+44 (0)7796 794 663/ +44 (0)7980 541 893
+ 44 (0)7867 984 082 / +44 (0)7407 804 654   

NCYT – Taiwan Disposal Update (PDF)